BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 37893564)

  • 1. Prevalence Rates of Arterial Hypertension According to the Threshold Criteria of 140/90 or 130/80 mmHg and Associated Cardiometabolic and Renal Factors: SIMETAP-HTN Study.
    Pallarés-Carratalá V; Ruiz-García A; Serrano-Cumplido A; Arranz-Martínez E; Divisón-Garrote JA; Moyá-Amengual A; Escobar-Cervantes C; Barrios V
    Medicina (Kaunas); 2023 Oct; 59(10):. PubMed ID: 37893564
    [No Abstract]   [Full Text] [Related]  

  • 2. Prevalence rates of chronic kidney disease and its association with cardiometabolic factors and cardiovascular diseases. SIMETAP-CKD study.
    Ruiz-Garcia A; Arranz-Martínez E; Iturmendi-Martínez N; Fernández-Vicente T; Rivera-Teijido M; García-Álvarez JC
    Clin Investig Arterioscler; 2023; 35(2):64-74. PubMed ID: 35945036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of prediabetes and association with cardiometabolic and renal factors. SIMETAP-PRED study.
    Arranz-Martínez E; Ruiz-García A; García Álvarez JC; Fernández Vicente T; Iturmendi Martínez N; Rivera-Teijido M;
    Clin Investig Arterioscler; 2022; 34(4):193-204. PubMed ID: 35120792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kidney measures with diabetes and hypertension on cardiovascular disease: the Atherosclerosis Risk in Communities Study.
    Alexander N; Matsushita K; Sang Y; Ballew S; Mahmoodi BK; Astor BC; Coresh J
    Am J Nephrol; 2015; 41(4-5):409-17. PubMed ID: 26139323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence rates of overweight and obesity and their associations with cardiometabolic and renal factors. SIMETAP-OB study.
    Ruiz-García A; Arranz-Martínez E; Morales-Cobos LE; García-Álvarez JC; Iturmendi-Martínez N; Rivera-Teijido M;
    Clin Investig Arterioscler; 2022; 34(6):291-302. PubMed ID: 35618556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of diabetes mellitus in Spanish primary care setting and its association with cardiovascular risk factors and cardiovascular diseases. SIMETAP-DM study.
    Ruiz-García A; Arranz-Martínez E; García-Álvarez JC; García-Fernández ME; Palacios-Martínez D; Montero-Costa A; Ciria-de-Pablo C; López-Uriarte B; García-Pliego RA; Chao-Escuer P; Zafra-Urango C; Alcaraz-Bethencourt A; Redondo-de-Pedro S; Escamilla-Guijarro N; Pascual-Val T; Vieira-Pascual MC; Martínez-Irazusta J; Martínez-Cid-de-Rivera E; Rodríguez-de-Cossío Á; de-Prado-Prieto L; Adrián-Sanz M; Minguela-Puras ME; Blanco-Canseco JM; Rubio-Villar M; Berbil-Bautista ML; Hueso-Quesada R; Plata-Barajas MT; Redondo-Sánchez M; Durán-Tejada MR; García-Redondo MR; Sánchez-Herráiz M; Rey-López AM; García-García-Alcañiz MP; Abad-Schilling C; Hidalgo-Calleja Y; Rivera-Teijido M;
    Clin Investig Arterioscler; 2020; 32(1):15-26. PubMed ID: 31130360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced Kidney Function Is Associated With Cardiometabolic Risk Factors, Prevalent and Predicted Risk of Cardiovascular Disease in Chinese Adults: Results From the REACTION Study.
    Lu J; Mu Y; Su Q; Shi L; Liu C; Zhao J; Chen L; Li Q; Yang T; Yan L; Wan Q; Wu S; Liu Y; Wang G; Luo Z; Tang X; Chen G; Huo Y; Gao Z; Ye Z; Wang Y; Qin G; Deng H; Yu X; Shen F; Chen L; Zhao L; Sun J; Sun W; Wang T; Du R; Lin L; Dai M; Xu Y; Xu M; Bi Y; Lai S; Li D; Wang W; Ning G;
    J Am Heart Assoc; 2016 Jul; 5(7):. PubMed ID: 27451464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heart Failure Prevalence Rates and Its Association with Other Cardiovascular Diseases and Chronic Kidney Disease: SIMETAP-HF Study.
    Ruiz-García A; Serrano-Cumplido A; Escobar-Cervantes C; Arranz-Martínez E; Turégano-Yedro M; Pallarés-Carratalá V
    J Clin Med; 2023 Jul; 12(15):. PubMed ID: 37568326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inadequate control of hypertension in US adults with cardiovascular disease comorbidities in 2003-2004.
    Wong ND; Lopez VA; L'Italien G; Chen R; Kline SE; Franklin SS
    Arch Intern Med; 2007 Dec; 167(22):2431-6. PubMed ID: 18071164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of rapid weight loss after bariatric surgery on the prevalence of arterial hypertension in severely obese patients with chronic kidney disease.
    Ortiz-Gomez C; Romero-Funes D; Gutierrez-Blanco D; Frieder JS; Fonseca-Mora M; Lo Menzo E; Szomstein S; Rosenthal RJ
    Surg Endosc; 2020 Jul; 34(7):3197-3203. PubMed ID: 31492989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sex differences in hypertension-related renal and cardiovascular diseases in Italy: the I-DEMAND study.
    Muiesan ML; Ambrosioni E; Costa FV; Leonetti G; Pessina AC; Salvetti M; Trimarco B; Volpe M; Pontremoli R; Deferrari G; Rosei EA
    J Hypertens; 2012 Dec; 30(12):2378-86. PubMed ID: 23137952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of echocardiographic changes in children with primary hypertension and hypertension due to mild to moderate chronic kidney disease.
    Paris G; Gorla SR; Arenas-Morales AJ; Seeherunvong W; Swaminathan S
    Pediatr Nephrol; 2019 Mar; 34(3):487-494. PubMed ID: 30276536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypertension is an important risk determinant for chronic kidney disease: results from a cross-sectional, observational study from a rural population in South India.
    Anupama YJ; Hegde SN; Uma G; Patil M
    J Hum Hypertens; 2017 May; 31(5):327-332. PubMed ID: 27882930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of Stenting for Atherosclerotic Renal Artery Stenosis on eGFR and Predictors of Clinical Events in the CORAL Trial.
    Tuttle KR; Dworkin LD; Henrich W; Greco BA; Steffes M; Tobe S; Shapiro JI; Jamerson K; Lyass A; Pencina K; Massaro JM; D'Agostino RB; Cutlip DE; Murphy TP; Cooper CJ
    Clin J Am Soc Nephrol; 2016 Jul; 11(7):1180-1188. PubMed ID: 27225988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in the prevalence, treatment and control of hypertension in Germany? A clinical-epidemiological study of 50.000 primary care patients.
    Labeit AM; Klotsche J; Pieper L; Pittrow D; Einsle F; Stalla GK; Lehnert H; Silber S; Zeiher AM; März W; Wehling M; Wittchen HU
    PLoS One; 2012; 7(12):e52229. PubMed ID: 23284945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular events and mortality in chronic kidney disease in primary care patients with previous type 2 diabetes and/or hypertension. A population-based epidemiological study (KIDNEES).
    Cunillera-Puértolas O; Vizcaya D; Cerain-Herrero MJ; Gil-Terrón N; Cobo-Guerrero S; Salvador-González B
    BMC Nephrol; 2022 Nov; 23(1):376. PubMed ID: 36585634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of stroke and coronary heart disease among various levels of blood pressure in diabetic and nondiabetic Chinese patients.
    Zhang Y; Jiang X; Bo J; Yin L; Chen H; Wang Y; Yu H; Wang X; Li W;
    J Hypertens; 2018 Jan; 36(1):93-100. PubMed ID: 29210861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dipping Status, Ambulatory Blood Pressure Control, Cardiovascular Disease, and Kidney Disease Progression: A Multicenter Cohort Study of CKD.
    Borrelli S; Garofalo C; Gabbai FB; Chiodini P; Signoriello S; Paoletti E; Ravera M; Bussalino E; Bellizzi V; Liberti ME; De Nicola L; Minutolo R
    Am J Kidney Dis; 2023 Jan; 81(1):15-24.e1. PubMed ID: 35709922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood pressure and coronary heart disease in NIDDM subjects at diagnosis: prevalence and risks in a Bangladeshi population.
    Sayeed MA; Banu A; Malek MA; Khan AK
    Diabetes Res Clin Pract; 1998 Feb; 39(2):147-55. PubMed ID: 9597385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence, pharmacological treatment, and control of cardiometabolic risk factors among older people in central Stockholm: a population-based study.
    Wang R; Fratiglioni L; Liang Y; Welmer AK; Xu W; Mangialasche F; Johnell K; Qiu C
    PLoS One; 2015; 10(3):e0119582. PubMed ID: 25799502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.